GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LENZ Therapeutics Inc (NAS:LENZ) » Definitions » Price-to-Owner-Earnings

LENZ (LENZ Therapeutics) Price-to-Owner-Earnings : (As of May. 13, 2025)


View and export this data going back to 2024. Start your Free Trial

What is LENZ Therapeutics Price-to-Owner-Earnings?

As of today (2025-05-13), LENZ Therapeutics's share price is $28.96. LENZ Therapeutics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for LENZ Therapeutics's Price-to-Owner-Earnings or its related term are showing as below:


LENZ's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.9
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-13), LENZ Therapeutics's share price is $28.96. LENZ Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-1.77. Therefore, LENZ Therapeutics's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-13), LENZ Therapeutics's share price is $28.96. LENZ Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in was $-1.77. Therefore, LENZ Therapeutics's PE Ratio without NRI for today is At Loss.


LENZ Therapeutics Price-to-Owner-Earnings Historical Data

The historical data trend for LENZ Therapeutics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LENZ Therapeutics Price-to-Owner-Earnings Chart

LENZ Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
- - - -

LENZ Therapeutics Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of LENZ Therapeutics's Price-to-Owner-Earnings

For the Biotechnology subindustry, LENZ Therapeutics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LENZ Therapeutics's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LENZ Therapeutics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where LENZ Therapeutics's Price-to-Owner-Earnings falls into.


;
;

LENZ Therapeutics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

LENZ Therapeutics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=28.96/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LENZ Therapeutics  (NAS:LENZ) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


LENZ Therapeutics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of LENZ Therapeutics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


LENZ Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA, USA, 92075
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.